Insider · CIK 0001246842
Mark A Goldsmith
officerdirector
Files at RVMD (Revolution Medicines, Inc.). First filing Oct 15, 2024, latest Sep 18, 2026.
Mark A Goldsmith files SEC Form 4 as officer and director at RVMD (Revolution Medicines, Inc.). Since Oct 15, 2024, Mark A Goldsmith has reported 0 open-market buys worth $0 and 18 open-market sells worth $65M, the latest filed on Sep 18, 2026.
A track record needs three past buys with six months of prices behind them; Mark A Goldsmith has 0, so none is measured yet.
The newest scored trade: sold $2.8M of RVMD on Sep 16, 2026, filed Sep 18, 2026, scored 35 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 12 sells worth $57M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 18
$0 bought, $65M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RVMD: Revolution Medicines, Inc.
RVMDOct 9, 2026 · close 189.76
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Revolution Medicines, Inc. | $2.8M 13,988 shares | -5% | +361% from low-11% from high | |
| 25Weak | Revolution Medicines, Inc. | $18M 86,000 shares | -25% | +487% from low-3% from high | |
| 35Weak | Revolution Medicines, Inc. | $1.6M 10,020 shares | -4% | +351% from low-4% from high | |
| 23Weak | Revolution Medicines, Inc. | $18M 120,000 shares | -30% | +340% from low0% from high | |
| 35Weak | Revolution Medicines, Inc. | $1.3M 12,871 shares | -4% | +218% from low-20% from high | |
| 10Weak | Revolution Medicines, Inc. | $3.6M 36,000 shares | -11% | +226% from low-18% from high | |
| 35Weak | Revolution Medicines, Inc. | $1.2M 15,394 shares | -6% | +149% from low-3% from high | |
| 25Weak | Revolution Medicines, Inc. | $5.0M 66,000 shares | -21% | +145% from low0% from high | |
| 20Weak | Revolution Medicines, Inc. | $1.4M 20,000 shares | -7% | +127% from low0% from high | |
| 20Weak | Revolution Medicines, Inc. | $1.3M 20,000 shares | -7% | +111% from low0% from high | |
| 20Weak | Revolution Medicines, Inc. | $1.8M 30,000 shares | -8% | +96% from low-1% from high | |
| 20Weak | Revolution Medicines, Inc. | $1.1M 20,000 shares | -4% | +60% from low-18% from high | |
| 30Weak | Revolution Medicines, Inc. | $615k 13,411 shares | -3% | +44% from low-26% from high | |
| 29Weak | Revolution Medicines, Inc. | $538k 13,496 shares | -3% | +28% from low-34% from high | |
| 27Weak | Revolution Medicines, Inc. | $458k 11,738 shares | -3% | +6% from low-35% from high | |
| 28Weak | Revolution Medicines, Inc. | $532k 11,714 shares | -3% | - | |
| 25Weak | Revolution Medicines, Inc. | $3.9M 70,000 shares | -23% | - | |
| 20Weak | Revolution Medicines, Inc. | $1.5M 30,000 shares | -9% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 15, 2026 | RVMD Revolution Medicines, Inc. | 13,603 0.01% of outstanding | $2.8M | Sep 15, 2026 | $20M |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | 80,000 0.04% of outstanding | $17M | Aug 21, 2026 | $1.6M |
| Aug 21, 2026 | RVMD REVOLUTION MEDICINES INC | 3,000 0.00% of outstanding | $635k | Aug 21, 2026 | $1.6M |
| Aug 21, 2026 | RVMD REVOLUTION MEDICINES INC | 3,000 0.00% of outstanding | $635k | Aug 21, 2026 | $1.6M |
| Jun 15, 2026 | RVMD Revolution Medicines, Inc. | 9,772 0.00% of outstanding | $1.5M | Jun 15, 2026 | $19M |
| Apr 15, 2026 | RVMD REVOLUTION MEDICINES INC | 120,000 0.06% of outstanding | $18M | Apr 15, 2026 | $4.9M |
| Mar 13, 2026 | RVMD Revolution Medicines, Inc. | 13,261 0.01% of outstanding | $1.3M | Mar 16, 2026 | $4.8M |
| Mar 2, 2026 | RVMD REVOLUTION MEDICINES INC. | 30,000 0.02% of outstanding | $3.1M | Mar 2, 2026 | $1.2M |
| Mar 2, 2026 | RVMD REVOLUTION MEDICINES INC | 3,000 0.00% of outstanding | $306k | Mar 2, 2026 | $1.2M |
| Mar 2, 2026 | RVMD REVOLUTION MEDICINES INC | 3,000 0.00% of outstanding | $306k | Mar 2, 2026 | $1.2M |
| Dec 12, 2025 | RVMD Revolution Medicines, Inc. | 14,964 0.01% of outstanding | $1.2M | Dec 15, 2025 | $11M |
| Nov 25, 2025 | RVMD REVOLUTION MEDICINES, INC. | 60,000 0.03% of outstanding | $4.4M | Nov 25, 2025 | $6.2M |
| Nov 25, 2025 | RVMD REVOLUTION MEDICINES INC | 3,000 0.00% of outstanding | $221k | Nov 25, 2025 | $6.2M |
| Nov 25, 2025 | RVMD REVOLUTION MEDICINES INC | 3,000 0.00% of outstanding | $221k | Nov 25, 2025 | $6.2M |
| Nov 18, 2025 | RVMD REVOLUTION MEDICINES INC | 20,000 0.01% of outstanding | $1.4M | Nov 18, 2025 | $4.8M |
| Nov 12, 2025 | RVMD REVOLUTION MEDICINES,INC. | 20,000 0.01% of outstanding | $1.3M | Nov 12, 2025 | $3.5M |
| Nov 7, 2025 | RVMD REVOLUTION MEDICINES, INC. | 30,000 0.02% of outstanding | $1.8M | Nov 7, 2025 | $1.7M |
| Oct 17, 2025 | RVMD REVOLUTION MEDICINES INC | 10,000 0.01% of outstanding | $497k | Oct 17, 2025 | $1.1M |
| Oct 16, 2025 | RVMD REVOLUTION MEDICINES, INC. | 10,000 0.01% of outstanding | $496k | Oct 16, 2025 | $615k |
| Sep 15, 2025 | RVMD Revolution Medicines, Inc. | 13,236 0.01% of outstanding | $616k | Sep 15, 2025 | $538k |
| Jun 13, 2025 | RVMD Revolution Medicines, Inc. | 13,235 0.01% of outstanding | $540k | Jun 16, 2025 | $458k |
| Mar 14, 2025 | RVMD Revolution Medicines, Inc. | 11,890 0.01% of outstanding | $462k | Mar 17, 2025 | $532k |
| Dec 16, 2024 | RVMD Revolution Medicines, Inc. | 11,561 0.01% of outstanding | $519k | Dec 16, 2024 | $6.4M |
| Nov 1, 2024 | RVMD REVOLUTION MEDICINES INC | 60,000 0.04% of outstanding | $3.2M | Nov 1, 2024 | $2.0M |
| Nov 1, 2024 | RVMD REVOLUTION MEDICINES INC | 5,000 0.00% of outstanding | $268k | Nov 1, 2024 | $2.0M |
Transactions
The newest 50 of 98 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -213 | $195.01 | $42k | 267,117 | 25 d ago |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -13,775 | $199.30 | $2.7M | 253,342 | 25 d ago |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +80,000 | $4.73 | $378k | 347,330 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -5,128 | $207.23 | $1.1M | 342,202 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -24,917 | $208.37 | $5.2M | 317,285 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -35,938 | $209.26 | $7.5M | 281,347 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,813 | $210.25 | $802k | 277,534 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -6,583 | $211.33 | $1.4M | 270,951 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,621 | $212.08 | $768k | 267,330 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -190 | $207.25 | $39k | 64,234 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -951 | $208.36 | $198k | 63,283 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -1,351 | $209.28 | $283k | 61,932 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -136 | $210.40 | $29k | 61,796 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -245 | $211.47 | $52k | 61,551 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -127 | $212.06 | $27k | 61,424 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -177 | $207.25 | $37k | 64,247 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -937 | $208.36 | $195k | 63,310 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -1,405 | $209.27 | $294k | 61,905 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -126 | $210.40 | $27k | 61,779 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -229 | $211.46 | $48k | 61,550 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -126 | $212.06 | $27k | 61,424 | Aug 25, 2026 |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -80,000 | $0.00 | $0 | 344,085 | Aug 25, 2026 |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -10,020 | $156.12 | $1.6M | 267,330 | Jun 18, 2026 |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +23,244 | $4.09 | $95k | 299,942 | Apr 17, 2026 |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +96,756 | $4.73 | $458k | 396,698 | Apr 17, 2026 |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -120,000 | $150.09 | $18M | 276,698 | Apr 17, 2026 |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -23,244 | $0.00 | $0 | 24,464 | Apr 17, 2026 |
| Apr 15, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -96,756 | $0.00 | $0 | 424,085 | Apr 17, 2026 |
| Mar 17, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -12,871 | $99.48 | $1.3M | 276,698 | Mar 19, 2026 |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Common Stock10b5-1 | +57,100 | $0.00 | $0 | 289,569 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +30,000 | $4.09 | $123k | 319,569 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -700 | $98.17 | $69k | 318,869 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,500 | $99.76 | $349k | 315,369 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -3,620 | $100.73 | $365k | 311,749 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -21,329 | $101.60 | $2.2M | 290,420 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -851 | $102.20 | $87k | 289,569 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -100 | $98.31 | $9,831 | 67,324 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -400 | $100.12 | $40k | 66,924 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -1,700 | $101.47 | $173k | 65,224 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -800 | $102.00 | $82k | 64,424 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -100 | $98.29 | $9,829 | 67,324 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -600 | $100.19 | $60k | 66,724 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -2,100 | $101.63 | $213k | 64,624 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stockindirect: Trust10b5-1 | -200 | $102.08 | $20k | 64,424 | Mar 3, 2026 |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +128,600 | $0.00 | $0 | 128,600 | Mar 3, 2026 |
| Mar 2, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -30,000 | $0.00 | $0 | 47,708 | Mar 3, 2026 |
| Feb 6, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock | +24,010 | $0.54 | $13k | 256,479 | Feb 10, 2026 |
| Feb 6, 2026 | RVMD Revolution Medicines, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -24,010 | $0.00 | $0 | 144,493 | Feb 10, 2026 |
| Dec 16, 2025 | RVMD Revolution Medicines, Inc. | SOpen-market sale Common Stock10b5-1 | -15,394 | $76.82 | $1.2M | 232,469 | Dec 18, 2025 |
| Nov 25, 2025 | RVMD Revolution Medicines, Inc. | MOption exercise Common Stock10b5-1 | +60,000 | $4.09 | $245k | 307,863 | Nov 26, 2025 |
50 of 98 rows shown.
Questions about Mark A Goldsmith
Answered from the filings on this page, as of the latest one.
Is Mark A Goldsmith buying or selling?
In the last 12 months Mark A Goldsmith reported 0 open-market buys worth $0 and 12 open-market sells worth $57M on SEC Form 4; the latest was sold $2.8M of RVMD on Sep 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Mark A Goldsmith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark A Goldsmith has 0.
Where does Mark A Goldsmith file Form 4?
Mark A Goldsmith has filed Form 4 at RVMD (Revolution Medicines, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.